Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments. - Wikidata - wikimedia - TriplyDB

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

http://www.wikidata.org/entity/Q35708164

about

Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.Acute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.Assessment of morphine-induced hyperalgesia and analgesic tolerance in mice using thermal and mechanical nociceptive modalities.BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice Therapies in early development for the treatment of opiate addiction.Opioid adjuvant strategy: improving opioid effectiveness.What's in a Name? Roles of RFamide-Related Peptides Beyond Gonadotrophin Inhibition.Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia.NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia.The effect of neuropeptide FF in the amygdala kindling model.Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology

P2860

Q27025236-49A034EE-7AEF-422B-B1C2-D9119EA7F508 Q34039598-C8F0145C-416F-4DE3-BB71-581AB587DA73 Q34525251-5D161F30-7951-4C48-B6F8-AE1A04A58527 Q34634103-430F8BAC-41AF-4557-9EC5-A638FAB7859E Q35921655-40331ACE-1638-4F13-83BB-04D697FA2BE7 Q35963214-D2C83665-4740-416D-80A5-DD6342F9A00A Q36407701-D67347EA-BA57-4CCE-ADB5-8C05D2A7C9C1 Q36903414-4C1EB183-7961-42BC-914D-CB44137E5822 Q38594606-D010514E-7CAE-43C6-ABA5-CE62F2C56C84 Q38742586-9C9207A8-DCF1-4CAA-BEDF-E52C40EB5D12 Q38883710-24B94222-47EF-4BD7-BB97-1E0D1E9F3275 Q42072640-F6C2ADA7-6595-44F2-A146-4C61C8C6768A Q48255291-1B15D02E-789D-449B-9F0B-27983C951F79 Q49103455-CAB9A7FA-1D16-4C3C-BF3D-EFDAD14EB1A4 Q57462903-EC1707C2-F488-40C4-8C32-DB86FF36BF88

P2860

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

http://www.wikidata.org/entity/Q35708164

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@ast

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@en

type

label

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@ast

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@en

prefLabel

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@ast

Involvement of neuropeptide FF ...... and chronic opiate treatments.

@en

P1433

Q35708164-05921EC5-46ED-4C67-A473-CEACB1CA30E0

P1476

Q35708164-548A232B-F130-4857-A820-3E055ADDC539

P2093

Q35708164-4276CF96-4472-41CE-837F-CB1BCBBE40C4

Q35708164-6F9427CF-5ADB-4FAF-8782-7AC1FF2BCE7A

Q35708164-76C9DF27-F3B6-4568-B106-FCE24BD42969

Q35708164-939B4B7A-A90B-42B7-9790-FAF8F35A5E86

Q35708164-9F4B2EDB-AB96-4145-993F-564DBC81E172

Q35708164-BB652967-19E4-46E5-AAF0-68330599027C

Q35708164-BD28AC0E-28FF-4E74-BB4D-031906B85883

Q35708164-C295DA7B-CAA0-4B55-89C6-2308BBE11E1B

Q35708164-CC342245-B6F1-46CD-84CA-073FDB987E07

Q35708164-EBC7556F-B1E0-4292-964B-583AA45813B8

P2860

Q35708164-059C2F86-3ADC-4457-91A7-07DBCF384BB9

Q35708164-128BA77D-7035-43B4-907B-90C99A0BA268

Q35708164-1CC363C9-963E-485D-911B-6C8BA210B4AF

Q35708164-291C8918-D8CA-48FB-B197-842BB24709A4

Q35708164-31B79FB4-D3CD-4810-92B5-DCBA9F886CF2

Q35708164-3D18E9A0-08F5-40BC-97C1-A2FF3E6847E7

Q35708164-422D6F04-ABE1-419A-9655-1A8E61D50052

Q35708164-43026C0E-73F7-4527-ADBE-49143853BC88

Q35708164-45C6D1A6-BD1F-44D6-8231-D28976F42595

Q35708164-4770E221-17BF-491C-BD6A-4544C9A8D316

P304

Q35708164-F1209408-1497-4286-AA1C-3C8178271461

P31

Q35708164-7CE6272A-8EA2-4479-9A98-2E4772F4FA1D

P356

Q35708164-1C0CF11A-9C5F-40FE-B681-961E37AF7FEC

P407

Q35708164-07949D46-85F9-4076-A2BF-D4A7EDF099AB

P433

Q35708164-E014F684-C594-42D7-AB72-B58FC4A3548A

P478

Q35708164-1439CBAB-4C77-47AF-9E30-A9DE811E3E19

P50

Q35708164-84EEC66E-C49D-4C82-8ACF-71B72A1D772F

Q35708164-C94CB454-DE30-47D1-B096-29965666FB33

Q35708164-D0CE149D-FE08-4F99-8ABC-22002F137445

P577

Q35708164-AFF0B2B8-5C98-42B8-973F-859FED4A32A8

P5875

Q35708164-37A0DE0E-F240-4E6A-B3A4-EF8E3936C9CD

P698

Q35708164-0D022EC4-DCD8-4E18-B79E-857B21269E00

P932

Q35708164-3036A03C-1ECB-42A0-9BE2-74C6A77BCAA9

P356

J.1476-5381.2011.01563.X

P1433

British Journal of Pharmacology

P1476

Involvement of neuropeptide FF ...... and chronic opiate treatments

@en

P2093

B Petit-demoulière

http://www.w3.org/2001/XMLSchema#string

F Bockel

http://www.w3.org/2001/XMLSchema#string

F Simonin

http://www.w3.org/2001/XMLSchema#string

H Meziane

http://www.w3.org/2001/XMLSchema#string

J J Bourguignon

http://www.w3.org/2001/XMLSchema#string

J M Trigo

http://www.w3.org/2001/XMLSchema#string

J-M Zajac

http://www.w3.org/2001/XMLSchema#string

K Elhabazi

http://www.w3.org/2001/XMLSchema#string

M Schmitt

http://www.w3.org/2001/XMLSchema#string

R Maldonado

http://www.w3.org/2001/XMLSchema#string

P2860

Morphine hyperalgesia: a case report

Mechanisms underlying morphine analgesic tolerance and dependence

Induction of synaptic long-term potentiation after opioid withdrawal

Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells

Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

P304

424-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01563.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Bihel

Lionel Moulédous

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51456802

http://www.w3.org/2001/XMLSchema#string

P698

21718302

http://www.w3.org/2001/XMLSchema#string

P932

3268196

http://www.w3.org/2001/XMLSchema#string